OSBORN WILLIAM A 4
4 · ABBOTT LABORATORIES · Filed Oct 27, 2021
Insider Transaction Report
Form 4
OSBORN WILLIAM A
Director
Transactions
- Exercise/Conversion
Common shares without par value
2021-10-26$59.42/sh+15,752$935,984→ 96,996 total - Exercise/Conversion
Option (right to buy)
2021-10-26−15,752→ 0 totalExercise: $59.42From: 2018-04-27Exp: 2028-04-26→ Common Shares (15,752 underlying)
Footnotes (1)
- [F1]Stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.